BG Medicine down hard after Q2 earnings report

|About: BG Medicine, Inc. (BGMD)|By:, SA News Editor

BG Medicine (BGMD -18%) takes a hit after reporting its Q2 earnings this morning.

Its net loss came in at $4.8M, a 25% reduction from the net loss reported in Q212.

The company expects FY13 revenue to range between $3.8M to $4M.

Operating cash burn for  FY13 will range from $15.5M to $16.5M and principal payments on its term loan to be $2.5M.